Skip to main content
. 2011 Jan 12;12:22. doi: 10.1186/1471-2164-12-22

Table 2.

Primers used for assay design.

Target LTR status Polarity Sequence Position Target Polarity Sequence Position
Intronic HERV-W proviral element (3' region) Gene harboring provirus

Sense
CD72 intron 1 3' F TGTCTCCAATTTTAACCCTATTTGC chr9:35629741 CD72 exon 1~2 F CTCTAGCTGATCGACTCACAAATACC AK311283
R TTCCCCAGCCAGCATGTAA chr9:35629792 R TGAACATTCTCGTAGGTGATTTCC
TBX18 intron 7 5'&3' F CCATTCCATGTTCCTCATTAAATCT chr6:85477157 TBX18 exon 7~8 F CCCAAGCAAGAATACAGGGACTT BC040697
R AGGCAATCTTACCACCCAGAAG chr6:85477208 R GGTTTCCCTTGAGACCAAATTG

Antisense
ACOX3 intron 1 5'&3' F AGACGCTTGGAGCAGTTTCTG chr4:8480630 ACOX3 exon 1~2 F CTGTGGAGTGTGTGGGCTCTT AK225080
R TCGGAGGACTTTACACATTGAACTAG chr4:8480744 R CAGAGCTGTGTCGCCTCCTT
KYNU intron 2 5'&3' F AGTGGGAATACTGACGCTCTTACC chr2:143372701 KYNU exon 2~3 F ACAGGATCTGCCTCCAGTTGA U57721
R GCCAAGAACCCAAGGTCAGA chr2:143372792 R TGGCCCACTTATCTAGTTCTTCTTC
THEM2 intron 1 5' F TGAGATACCAGAGATCACCAAACTCTT chr6:24787905 THEM2 exon 1~2 F GGGAGGTGATAAAGGCCATGA BC000894
R TGAAGTTTTATAAGGGTTAGGACAATCTT chr6:24788017 R GGAGCAGCAGAGACAAGAGTAATCT
ZNF678 intron 1 5'&3' F GGAAATGAACATAGTCTTACTGTCAGGTA chr1:225878139 ZNF678 exon 1~2 F TGCAGGTACTGGGAGTTACATAGC BC042500
R CATAGAGTCCAGAAATGTGTCTATCCA chr1:225878254 R TGCCAGTAGTCCCGTTTTCC
ANO3 intron 14 3' F AAAGGATTGTGTAAGAGAAGCTGATAAGA chr11:26568090 ANO3 exon 14~15 F TTGTTCGATAATGGAGGGACAGT BC172396
R GCAGAGATGTTATCCCTGTTGGT chr11:26568167 R CGATAAGGTCCCAAGTATAGGTCAGT

Intronic HERV-W proviral element (5' region)

CD72 intron 1 F GCAGAGGTCTACTCACACCATAGC chr9:35633414
R GGCAATCAGGAGGCCTAAA chr9:35633462
TBX18 intron 7 F GGGCTACAGTGATCCATTTATAAGG chr6:85488459
R AAACTTTATCCAAACATTCCCTATGTTAG chr6:85488532
ANO3 intron 14 F TCTCCTTCACCACGAGAGTTTG chr11:26576040
R TGCTACTCGTCCAGAGCTTACAGA chr11:26576091

Intronic HERV-W pseudoelement (3' region) Gene harboring pseudoelement

Sense
SLC16A10 intron 1 F TGGCAGTGCTCGTTGAATGT chr6:111566680 SLC16A10 exon 1~2 F GGCTCCAAAGACGATGACAAG BC034031
R ACATAAGCCCCAAAACTGTCAGA chr6:111566728 R AAATCATCCCCATGGAGAGAGA
AK024261 intron 1 F GGCCCACCTCCAGCAAA chr2:218160716 AK024261 exon 1~2 F CAGCAGATGATGGTGATGGAA AK024261
R TGGGTGTGATCAGGTCATGGT chr2:218160778 R CATCCCTCGGACTCAGTTTCTC

Antisense
FOXP2 intron 3 F CAAGAGGACATCTCTAAATCAAAGACTGT chr7:113805180 FOXP2 exon 3~4 F GCGAGGTTAATTCGAAAGTCTTGTGGAA AF454830
R GAGCATGCCAGGCAAAGC chr7:113805235 R TTGCTTATTGTCTCTGTCGCAGAT
APG5 intron 6 F TCAAATCACACAATGCTCCAATG chr6:106791850 APG5 exon 6~7 F ATCCCCTTTAGAATATATCAGACAACGA BC093011
R TTAGCAGTTGCATATGAGATCTTTCA chr6:106791905 R CCTAGTGTGTGCAACTGTCCATCT
KIAA0423 intron7 F GACATGAATATTTTTTGTGGACATAACTC chr14:44557550 KIAA0423 exon 7~8 F CCAACAAGACTTTCTTCTGCAAAG AB007883
R GCCAAACAGAACAGTACTAAACTATATTATAGACT chr14:44557636 R TTTGCTGTGGATTTGATGATGAC
NRCAM intron 2 F AAGTCTGGGTTCCAGGTTCATC chr7:107772873 NRCAM exon 2~3 F GCTGGTCTTAGCTGTTGGCATT BC115736
R CTGAGGAACCTTTCTGAGTTGAGTAA chr7:107772929 R CGTCTTCTTAGCATTGCTCTTCAG
ZMAT3 intron 2 F GGATTCCCAGGTACGGTGAAA chr3:180258291 ZMAT3 exon 2~3 F CTCTGCAATGTCACCTTGAACTCT BC002896
R CCTAGAAAGCTACTTCCGCTTCAG chr3:180258381 R GCTGCATAGTAATTTCGGAGTTTCT

Intronic HERV-W pseudoelement (5' region)

SLC16A10 intron 1 F CAAGAGGACATCTCTAAATCAAAGACTGT chr6:111558508
R GAGCATGCCAGGCAAAGC chr6:111558555
FOXP2 intron 3 F TCAAATCACACAATGCTCCAATG chr7:113813845
R TTAGCAGTTGCATATGAGATCTTTCA chr7:113813901
NRCAM intron 2 F GACATGAATATTTTTTGTGGACATAACTC chr7:107763923
R GCCAAACAGAACAGTACTAAACTATATTATAGACT chr7:107763973

Intronic solitary LTR Gene harboring solitary LTR

Sense
ZNF 277 intron 1 F AGAACCCAGGTCAGAAAACAAGAG chr7:111648615 ZNF277 exon 1~2 F GGCTGTCGCCCGAATG AF209198
R CAGTCCCTGGTGCCAAGAAG chr7:111648735 R ACAATCCTTACTGTCCCCATAACC
WDR72 intron 14 F AAACACTATCTGATTGCCTGACAGA chr15:51704774 WDR72 exon 14~15 F CCAGCTTGGGCCATTACCTT BX53788
R CCAGGACCTTGTCTATGATGCA chr15:51704828 R GCAAAATTTGGCATCAGTAACCT
chrXq13.1 F CAGGTCCATTTAAAGCCCAAGT chrX:71350691 PIN4 exon 3~4 F CAGGTCCATTTAAAGCCCAAGT AK12760
R CCTGAAAGTGAAGCCAAAAGGA chrX:71350741 R CCTGAAAGTGAAGCCAAAAGGA
chrXq26.2 F TGGGAGAAGCAATGTCCAATT chrX:131380909 MBNL3 exon 1~2 F TGGCCTGTTTTGATTCTCTAAAGG AB077698
R TTTGTCAAGTCATGGCCGTTT chrX:131380961 R AGTGTGGAGGAGGGTGAAGGT

Antisense
C9orf85 intron 2 F ACCCACCAATTCCGGATACA chr9:73769452 C9orf85 exon 2~3 F GAGTGGCGTGTAAAATACAGCAAA BC052375
R TGGCCCAAGATTTCATTCCT chr9:73769523 R CATGGCCTGCACATTATGTGA
UBD exon 1~2 F GATGGCTCCCAATGCTTCCT AF123050
R TGGCATCAAAGGTCATTAAATCC
chr6p22.1 F GCCAGATAACCAGCTTCTCTTCA chr6:29635237 GABBR1 exon 18~19 F GGAGTCGAGTGCATTTGCTTTAT BC051463
R GAGAAGAGGCTGGCATTGACA chr6:29635286 R TGGCATCAAAGGTCATTAAATCC
chrXq13.1 ERCC6L exon 1~2 F GGAAGCCGAGGCCTTGAG BC111486
R TTAGTTGCTTCTTTGGCCTCTTTC
chrXq26.2 AK095439 exon 2~3 F ACTTCATTGAATGTCTTAGACGGAAA AK09543
R TCACATATGCAGTTATCAAAAGAGCTT

Intergenic HERV-W proviral element and adjacent genes Intergenic HERV-W pseudoelement and adjacent genes

LRIG3 (5') F TCGAGTAATTCTTTCATGGGTACCT AY505340 COBLL1 (5') F CAGAGTTTGCTGACTGCAATCC BC071588
R ATCTGATGGCTGTCCAAAGCTT R GACCTTCCATTCACAGATATTGTATTTG
pro chr12q14,1 F TGGTCAAGAGGAGTCCAGAGTTT chr12:57530852 pse chr2q24,3 F ACCTACACCAATTCAGCTGTTAAGG chr2:165222305
R GCCCACCAATGCAATGCT chr12:57530902 R CCACAATGCTCCGAGTTCACT chr2:165222360
AK093124 (3') F TGTCCCTTGCTACATACCTGCTT GRB14 (3') F TGTGCTGCAGACAGGCGAAAA
R TGCACTCAGATAAAGTGTCAATAAGAAG AK093124 R CAGATGTAAATGGAGAACAGCATAGC BC053559
GSTA4 N/A GRK7 (5') F TGCAGGCTCTTCTTGGCTAAG AF439409
R GTTTCCTGGGATCATCAGAATTTT
pro chr6p12,1 F GACCTTTTTCCTGGGCATCA chr6:52887125 pse chr3q23 F GGGTCCAAGGCTGCTCCTA chr3:143023903
R GGGTAGGTGAACATGCCAGAA chr6:52887169 R GGTAAGCCTCCTGCACTCTGA chr3:143023960
GSTA3 (3') F GCGGAGACCGGCTAGACTTT ATP1B3 N/A
R CCGTCCATTGAAGTAGTGAAGCT BC020619
AKR1B10 (5') F TGCTGAGGAGATGGCAACCAT B C008837 CLSTN3 (5') F GGGATGACTCAGCTCTCACCAT BC039075
R TCCAAATGAGAGGATTGCAACAC R TCACACAGGACTGCCGATTC
pro chr7q33 F TGGAAGAAACAAATTGCCTGATC chr7:133929406 pse chr12p13.31 F CAGAAAGGTTTTGCCTAGTAGTGTTG chr12:7230506
R AAATGCCCTTAGGCCAGATAGAT chr7:133929455 R TGTGCTGTACTTCTGCTTTTTAGAAAT chr12:7230605
BPGM (3') F GGTGGCCCCTTTGCAGAT PEX5 (3') F ATGCAGCAGATTGAGCAGTCA
R TGGACATACTGATGGCTGAACTTC BC01705 R CAGTTCTCAGACAAGGCCAAGTC AK301700
TMEM26 (5') F TGCCATCCTTGTTATATGGACTTG CR749606 INTS7 (5') F CACTGCAGAGTAAATCTGGACAAGA BC020523
R CAGGGCACACAACGTTCTGT R TCAACCCTTTGCTCCATCTCA
pro chr10q21.2 F TGAAACGTGTCATGTATCATCTCAA chr10:62462501 pse chr1q32.3 F TCTGATGAACTCTGAATAAACTCTTTCT chr1:210095554
R GGTAACACCCGGCCATTTT chr10:62462549 R G chr1:210095648
RHOBTB1 (3') F CCGCGGGAGCTTCCA LPGAT1 (3') F GATTGCATGCCCTAATTATGGAA
R CCATTTTCATAACTTAGTCAAGAATGCT BC093035 R CCCTGAGAGATCACCGAGAAAG BC034621
LRRK2 (5') F GGTACACAAAAGCAGAAAGAGATACAA chr7:133929455 RNGTT (5') F GCCACGGAGCTTCTTCCA BC019954
R TTTGCACTTCATGTGGAAGATTG R CAAAAGTTTTCCTAATGCCTACAACA
pro chr12q12 F GGGAGCAGATGAGGAGCAAA chr12:39072588 pse chr6q15 F CATCTCCTTGGTGACAGGGTTT chr6:89180050
R GGTGGACCTGGAAAATGGAA chr12:39072637 R TGGTCACTTGATTTATAAGAAACGTGTT chr6:89180152
CR749517 (3') F TTTGACTTACTCGTTCACTGTGATCA CNR1 (3') F CCACATAGGACTGGTTTTCAATTG
R TGTGGCTGCTGTGCTGAAA CR749517 R ATGCCTCCACCAGTGATTGC AK313908
GGCCATCTAGGATCGACTTCAT

Target, primer sequences and position of sequences used for assay design. The same orientation of HERV-W element or solitary LTR and genes harboring such elements is indicated by sense, whereas opposite orientation is indicated by anti-sense. For simplicity, intergenic HERV-W elements transcribed in the same orientation as their adjacent genes were selected. Genes located upstream and downstream of intergenic elements are labeled 5' and 3', respectively.